p53 Checkpoint-defective cells are sensitive to X rays, but not hypoxia

Experimental Cell Research

Volumn 258, Issue 1, 2000, Pages 82-91

  Denko, Nicholas C ^a   Green, Susannah L ^a   Edwards, Diana ^a   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Genomic instability; P21; Tumor microenvironment

Indexed keywords

CELL DNA; MESSENGER RNA; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL HYPOXIA; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; GENE INDUCTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN DEFECT; RADIOSENSITIVITY; REGULATORY MECHANISM; TUMOR CELL; X RAY;

TRIXIS;

EID: 0034632052     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4928     Document Type: Article

References (39)

1. Levine A. J., Wu M. C., Chang A., Silver A., Attiyeh E. F., Lin J., Epstein C. B. The spectrum of mutations at the p53 locus: Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann. N.Y. Acad. Sci. 768:1995;111-128.
2. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
3. Polyak K., Waldman T., He T. C., Kinzler K. W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1996;1945-1952.
4. Chen X., Ko L. J., Jayaraman L., Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:1996;2438-2451.
5. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
6. Waldman T., Kinzler K. W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
7. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J. P., Sedivy J. M., Kinzler K. W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501.
8. Waldman T., Lengauer C., Kinzler K. W., Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 381:1996;713-716.
9. Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nature Med. 3:1997;1034-1036.
10. Wouters B. G., Giaccia A. J., Denko N. C., Brown J. M. Loss of p21 Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res. 57:1997;4703-4706.
11. Bissonnette N., Hunting D. J. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene. 16:1998;3461-3469.
12. Gorospe M., Cirielli C., Wang X., Seth P., Capogrossi M. C., Holbrook N. J. p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
13. Asada M., Yamada T., Ichijo H., Delia D., Miyazono K., Fukumuro K., Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. EMBO J. 18:1999;1223-1234.
14. Brown J. M., Giaccia A. J. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58:1998;1408-1416.
15. Kim C. Y., Tsai M. H., Osmanian C., Graeber T. G., Lee J. E., Giffard R. G., DiPaolo J. A., Peehl D. M., Giaccia A. J. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 57:1997;4200-4204.
16. Graeber T. G., Osmanian C., Jacks T., Housman D. E., Koch C. J., Lowe S. W., Giaccia A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;88-91.
17. Teicher B. A. Hypoxia and drug resistance. Cancer Metastasis Rev. 13:1994;139-168.
18. Amellem O., Pettersen E. O. Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: The possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif. 24:1991;127-141.
19. Graeber T. G., Peterson J. F., Tsai M., Monica K., Fornace A. J. Jr., Giaccia A. J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell Biol. 14:1994;6264-6277.
20. Muschel R. J., Bernhard E. J., Garza L., McKenna W. G., Koch C. J. Induction of apoptosis at different oxygen tensions: Evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res. 55:1995;995-998.
21. Rice G. C., Hoy C., Schimke R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 83:1986;5978-5982.
22. Gartenhaus R. B., Wang P., Hoffmann P. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. Proc. Natl. Acad. Sci. USA. 93:1996;265-268.
23. Carmeliet P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C. J., Ratcliffe P., Moons L., Jain R. K., Collen D., Keshert E., Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490.
24. Lord E. M., Harwell L., Koch C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res. 53:1993;5721-5726.
25. Haapajarvi T., Kivinen L., Heiskanen A., des Bordes C., Datto M. B., Wang X. F., Laiho M. UV radiation is a transcriptional inducer of p21 (Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner. Exp. Cell Res. 248:1999;272-279.
26. Jin S., Antinore M. J., Lung F. D., Dong X., Chao H., Fan F., Colchagie A. B., Blanck P., Roller P. P., Fornace A. J. Jr., Zhan Q. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J. Biol. Chem. 2000.
27. Ravi R., Mookerjee B., Bhujwalla Z. M., Sutter C. H., Artemov D., Zeng Q., Dillehay L. E., Madan A., Semenza G. L., Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14:2000;34-44.
28. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
29. Alarcon R. M., Rupnow B. A., Graeber T. G., Knox S. J., Giaccia A. J. Modulation of c-Myc activity and apoptosis in vivo. Cancer Res. 56:1996;4315-4319.
30. Linke S. P., Clarkin K. C., Di Leonardo A., Tsou A., Wahl G. M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:1996;934-947.
31. Wang W., Furneaux H., Cheng H., Caldwell M. C., Hutter D., Liu Y., Holbrook N., Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20:2000;760-769.
32. Zhan Q., Antinore M. J., Wang X. W., Carrier F., Smith M. L., Harris C. C., Fornace A. J. Jr. Association with Cdc2 and inhibition of Cdc2/cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 18:1999;2892-2900.
33. Hollander M. C., Sheikh M. S., Bulavin D. V., Lundgren K., Augeri-Henmueller L., Shehee R., Molinaro T. A., Kim K. E., Tolosa E., Ashwell J. D., Rosenberg M. P., Zhan Q., Fernandez-Salguero P. M., Morgan W. F., Deng C. X., Fornace A. J. Jr. Genomic instability in Gadd45a-deficient mice. Nature Genet. 23:1999;176-184.
34. Guo C. Y., D'Anna J. A., Li R., Larner J. M. The radiation-induced S-phase checkpoint is independent of CDKN1A. Radiat. Res. 151:1999;125-132.
35. Nelson W. G., Kastan M. B. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1994;1815-1823.
36. Huang L. C., Clarkin K. C., Wahl G. M. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc. Natl. Acad. Sci. USA. 93:1996;4827-4832.
37. Canman C. E., Lim D. S., Cimprich K. A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M. B., Siliciano J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
38. Giaccia A. J., Kastan M. B. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
39. Kapoor M., Lozano G. Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl. Acad. Sci. USA. 95:1998;2834-2837.